Randomized Phase II Study of Gemcitabine Monotherapy vs. Gemcitabine with an EPA-Enriched Oral Supplement in Advanced Pancreatic Cancer-Reference-Cited by-同舟云学术

Randomized Phase II Study of Gemcitabine Monotherapy vs. Gemcitabine with an EPA-Enriched Oral Supplement in Advanced Pancreatic Cancer

Published:2021-01-13 Issue: Volume: Page:1-10
ISSN:0163-5581
Container-title:Nutrition and Cancer
language:en
Short-container-title:Nutrition and Cancer

Author:

Ueno Makoto¹^ORCID,Sugimori Kazuya²,Taguri Masataka³,Ohkawa Shinichi¹,Kobayashi Satoshi¹,Miwa Haruo²,Kaneko Takashi²,Morimoto Manabu¹,Yamanaka Takeharu³

Affiliation:

1. Division of Hepatobiliary and Pancreatic Medical Oncology, Kanagawa Cancer Center, Yokohama, Japan

2. Department of Gastroenterology, Yokohama City University Medical Center, Yokohama, Japan

3. Department of Biostatistics and Epidemiology, Yokohama City University Medical Center, Yokohama, Japan

Funder

Kanagawa Prefectural Hospitals Cancer Fund

Publisher

Informa UK Limited

Subject

Cancer Research,Nutrition and Dietetics,Oncology,Medicine (miscellaneous)

Link

https://www.tandfonline.com/doi/pdf/10.1080/01635581.2020.1871495

Reference22 articles.

1. Global cancer statistics

2. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.

3. FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer

4. Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine

5. Reduced total energy expenditure and physical activity in cachectic patients with pancreatic cancer can be modulated by an energy and protein dense oral supplement enriched with n-3 fatty acids

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Does the ratio of eicosapentaenoic acid to docosahexaenoic acid matter in cancer treatment? A systematic review of their effects on cachexia-related inflammation;Nutrition;2024-08

2. Dietary Supplements in People with Metastatic Cancer Who Are Experiencing Malnutrition, Cachexia, Sarcopenia, and Frailty: A Scoping Review;Nutrients;2022-06-26

3. Effects of perioperative eicosapentaenoic acid‑enriched oral nutritional supplement on the long‑term oncological outcomes after total gastrectomy for gastric cancer;Oncology Letters;2022-03-15